[Form 4] Aehr Test Systems Insider Trading Activity
Aehr Test Systems (AEHR) 鈥� Form 4 insider filing: Chief Technology Officer Donald P. Richmond II had 811 common shares withheld on 14 Jul 2025 (Transaction Code F) to cover tax obligations triggered by the vesting of restricted stock units (RSUs) at an indicated price of $13.86 per share. The filing explicitly notes that this is not an open-market sale; the shares were surrendered back to the issuer. After the withholding, Richmond still beneficially owns 214,694 shares, a figure that includes unvested RSUs. No derivative securities were reported, and there were no purchases or discretionary sales. Given the small number of shares involved (鈮�0.4 % of the insider鈥檚 holdings) and the routine nature of tax-related withholding, the transaction is viewed as administrative and immaterial to the company鈥檚 investment thesis.
Aehr Test Systems (AEHR) 鈥� Comunicazione interna Form 4: Il Chief Technology Officer Donald P. Richmond II ha trattenuto 811 azioni ordinarie il 14 luglio 2025 (Codice Transazione F) per coprire gli obblighi fiscali derivanti dalla maturazione delle unit脿 di azioni vincolate (RSU) a un prezzo indicato di 13,86 $ per azione. La comunicazione specifica chiaramente che non si tratta di una vendita sul mercato aperto; le azioni sono state restituite all鈥檈mittente. Dopo la trattenuta, Richmond detiene ancora 214.694 azioni a titolo benefico, comprensive delle RSU non ancora maturate. Non sono stati segnalati strumenti derivati, n茅 acquisti o vendite discrezionali. Considerando il numero esiguo di azioni coinvolte (circa lo 0,4% delle partecipazioni dell鈥檌nsider) e la natura ordinaria della trattenuta fiscale, l鈥檕perazione 猫 considerata amministrativa e irrilevante per la tesi d鈥檌nvestimento della societ脿.
Aehr Test Systems (AEHR) 鈥� Presentaci贸n interna Formulario 4: El Director de Tecnolog铆a Donald P. Richmond II tuvo 811 acciones ordinarias retenidas el 14 de julio de 2025 (C贸digo de Transacci贸n F) para cubrir obligaciones fiscales derivadas de la consolidaci贸n de unidades restringidas de acciones (RSU) a un precio indicado de 13,86 $ por acci贸n. La presentaci贸n aclara expl铆citamente que no se trata de una venta en el mercado abierto; las acciones fueron devueltas al emisor. Tras la retenci贸n, Richmond a煤n posee 214,694 acciones en beneficio propio, cifra que incluye RSU no consolidadas. No se reportaron valores derivados ni compras o ventas discrecionales. Dado el peque帽o n煤mero de acciones involucradas (鈮�0,4 % de las participaciones del insider) y la naturaleza rutinaria de la retenci贸n fiscal, la transacci贸n se considera administrativa e irrelevante para la tesis de inversi贸n de la empresa.
Aehr Test Systems (AEHR) 鈥� 雮措秬鞛� 鞁犼碃靹� Form 4: 斓滉碃旮办垹毂呾瀯鞛� Donald P. Richmond II電� 2025雲� 7鞗� 14鞚检棎 811欤� 氤错喌欤茧ゼ 鞗愳矞歆曥垬頄堨姷雼堧嫟(瓯半灅 旖旊摐 F). 鞚措姅 鞝滍暅 欤检嫕 雼渼(RSU)鞚� 甓岆Μ 頇曥爼鞐� 霐半ジ 靹戈笀 鞚橂毳� 於╇嫻頃橁赴 鞙勴暅 瓴冹溂搿�, 欤茧嫻 13.86雼煬鞚� 臧�瓴╈溂搿� 響滌嫓霅橃棃鞀惦媹雼�. 鞁犼碃靹滌棎電� 鞚措姅 瓿店皽 鞁滌灔 毵る弰臧� 鞎勲嫎鞚� 氇呾嫓霅橃柎 鞛堨溂氅�, 欤检嫕鞚� 氚滍枆靷棎 氚橅櫂霅橃棃鞀惦媹雼�. 鞗愳矞歆曥垬 頉� Richmond電� 鞐爠頌� 214,694欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨溂氅�, 鞚挫棎電� 鞎勳 甓岆Μ 頇曥爼霅橃 鞎婌潃 RSU霃� 韽暔霅╇媹雼�. 韺岇儩 歃濌秾鞚� 氤搓碃霅橃 鞎婌晿瓿�, 毵れ垬雮� 鞛勳潣 毵る弰霃� 鞐嗢棃鞀惦媹雼�. 甏�霠� 欤检嫕 靾橁皜 鞝侁碃(雮措秬鞛� 氤挫湢霟夓潣 鞎� 0.4%) 靹戈笀 甏�霠� 鞗愳矞歆曥垬鞚� 鞚检儊鞝� 靹标博鞚� 瓿犽牑頃� 霑�, 鞚� 瓯半灅電� 須岇偓鞚� 韴瀽 雲茧Μ鞐� 頄夓爼鞝侅澊瓿� 欷戩殧頃橃 鞎婌潃 瓴冹溂搿� 臧勳＜霅╇媹雼�.
Aehr Test Systems (AEHR) 鈥� D茅claration d鈥檌niti茅 Formulaire 4 : Le Directeur Technique Donald P. Richmond II a retenu 811 actions ordinaires le 14 juillet 2025 (Code de transaction F) afin de couvrir les obligations fiscales li茅es 脿 l鈥檃cquisition d鈥檜nit茅s d鈥檃ctions restreintes (RSU) 脿 un prix indiqu茅 de 13,86 $ par action. La d茅claration pr茅cise explicitement qu鈥檌l ne s鈥檃git pas d鈥檜ne vente sur le march茅 ouvert ; les actions ont 茅t茅 restitu茅es 脿 l鈥櫭﹎etteur. Apr猫s la retenue, Richmond d茅tient toujours 214 694 actions 脿 titre b茅n茅ficiaire, un chiffre incluant les RSU non acquises. Aucun instrument d茅riv茅 n鈥檃 茅t茅 d茅clar茅, et il n鈥檡 a eu ni achats ni ventes discr茅tionnaires. 脡tant donn茅 le faible nombre d鈥檃ctions concern茅es (鈮�0,4 % des avoirs de l鈥檌niti茅) et la nature routini猫re de la retenue fiscale, la transaction est consid茅r茅e comme administrative et sans impact sur la th猫se d鈥檌nvestissement de la soci茅t茅.
Aehr Test Systems (AEHR) 鈥� Insider-Meldung Form 4: Chief Technology Officer Donald P. Richmond II hat am 14. Juli 2025 insgesamt 811 Stammaktien einbehalten (Transaktionscode F), um Steuerverpflichtungen aus der Vesting von Restricted Stock Units (RSUs) zu erf眉llen, zu einem angegebenen Preis von 13,86 $ pro Aktie. In der Meldung wird ausdr眉cklich darauf hingewiesen, dass dies kein Verkauf am offenen Markt ist; die Aktien wurden an den Emittenten zur眉ckgegeben. Nach der Einbehaltung besitzt Richmond weiterhin 214.694 Aktien wirtschaftlich, einschlie脽lich unverfallbarer RSUs. Es wurden keine Derivate gemeldet, ebenso keine K盲ufe oder diskretion盲ren Verk盲ufe. Aufgrund der geringen Anzahl der betroffenen Aktien (ca. 0,4 % der Insider-Beteiligung) und der routinem盲脽igen Natur der steuerbedingten Einbehaltung wird die Transaktion als administrativ und unerheblich f眉r die Investmentthese des Unternehmens eingestuft.
- None.
- None.
Insights
TL;DR: Routine tax withholding; neutral impact.
The Code F transaction simply covers statutory withholding on vested RSUs. With just 811 shares involved and the insider retaining >214 k shares, the move neither signals confidence nor concern. It does not affect float, liquidity, or strategic direction. Market impact: negligible.
TL;DR: Compliance event, no governance red flags.
The disclosure satisfies Section 16(a) requirements in a timely manner. No pattern of insider selling is evident; ownership remains significant. This filing demonstrates standard corporate governance practice with no adverse implications.
Aehr Test Systems (AEHR) 鈥� Comunicazione interna Form 4: Il Chief Technology Officer Donald P. Richmond II ha trattenuto 811 azioni ordinarie il 14 luglio 2025 (Codice Transazione F) per coprire gli obblighi fiscali derivanti dalla maturazione delle unit脿 di azioni vincolate (RSU) a un prezzo indicato di 13,86 $ per azione. La comunicazione specifica chiaramente che non si tratta di una vendita sul mercato aperto; le azioni sono state restituite all鈥檈mittente. Dopo la trattenuta, Richmond detiene ancora 214.694 azioni a titolo benefico, comprensive delle RSU non ancora maturate. Non sono stati segnalati strumenti derivati, n茅 acquisti o vendite discrezionali. Considerando il numero esiguo di azioni coinvolte (circa lo 0,4% delle partecipazioni dell鈥檌nsider) e la natura ordinaria della trattenuta fiscale, l鈥檕perazione 猫 considerata amministrativa e irrilevante per la tesi d鈥檌nvestimento della societ脿.
Aehr Test Systems (AEHR) 鈥� Presentaci贸n interna Formulario 4: El Director de Tecnolog铆a Donald P. Richmond II tuvo 811 acciones ordinarias retenidas el 14 de julio de 2025 (C贸digo de Transacci贸n F) para cubrir obligaciones fiscales derivadas de la consolidaci贸n de unidades restringidas de acciones (RSU) a un precio indicado de 13,86 $ por acci贸n. La presentaci贸n aclara expl铆citamente que no se trata de una venta en el mercado abierto; las acciones fueron devueltas al emisor. Tras la retenci贸n, Richmond a煤n posee 214,694 acciones en beneficio propio, cifra que incluye RSU no consolidadas. No se reportaron valores derivados ni compras o ventas discrecionales. Dado el peque帽o n煤mero de acciones involucradas (鈮�0,4 % de las participaciones del insider) y la naturaleza rutinaria de la retenci贸n fiscal, la transacci贸n se considera administrativa e irrelevante para la tesis de inversi贸n de la empresa.
Aehr Test Systems (AEHR) 鈥� 雮措秬鞛� 鞁犼碃靹� Form 4: 斓滉碃旮办垹毂呾瀯鞛� Donald P. Richmond II電� 2025雲� 7鞗� 14鞚检棎 811欤� 氤错喌欤茧ゼ 鞗愳矞歆曥垬頄堨姷雼堧嫟(瓯半灅 旖旊摐 F). 鞚措姅 鞝滍暅 欤检嫕 雼渼(RSU)鞚� 甓岆Μ 頇曥爼鞐� 霐半ジ 靹戈笀 鞚橂毳� 於╇嫻頃橁赴 鞙勴暅 瓴冹溂搿�, 欤茧嫻 13.86雼煬鞚� 臧�瓴╈溂搿� 響滌嫓霅橃棃鞀惦媹雼�. 鞁犼碃靹滌棎電� 鞚措姅 瓿店皽 鞁滌灔 毵る弰臧� 鞎勲嫎鞚� 氇呾嫓霅橃柎 鞛堨溂氅�, 欤检嫕鞚� 氚滍枆靷棎 氚橅櫂霅橃棃鞀惦媹雼�. 鞗愳矞歆曥垬 頉� Richmond電� 鞐爠頌� 214,694欤茧ゼ 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨溂氅�, 鞚挫棎電� 鞎勳 甓岆Μ 頇曥爼霅橃 鞎婌潃 RSU霃� 韽暔霅╇媹雼�. 韺岇儩 歃濌秾鞚� 氤搓碃霅橃 鞎婌晿瓿�, 毵れ垬雮� 鞛勳潣 毵る弰霃� 鞐嗢棃鞀惦媹雼�. 甏�霠� 欤检嫕 靾橁皜 鞝侁碃(雮措秬鞛� 氤挫湢霟夓潣 鞎� 0.4%) 靹戈笀 甏�霠� 鞗愳矞歆曥垬鞚� 鞚检儊鞝� 靹标博鞚� 瓿犽牑頃� 霑�, 鞚� 瓯半灅電� 須岇偓鞚� 韴瀽 雲茧Μ鞐� 頄夓爼鞝侅澊瓿� 欷戩殧頃橃 鞎婌潃 瓴冹溂搿� 臧勳＜霅╇媹雼�.
Aehr Test Systems (AEHR) 鈥� D茅claration d鈥檌niti茅 Formulaire 4 : Le Directeur Technique Donald P. Richmond II a retenu 811 actions ordinaires le 14 juillet 2025 (Code de transaction F) afin de couvrir les obligations fiscales li茅es 脿 l鈥檃cquisition d鈥檜nit茅s d鈥檃ctions restreintes (RSU) 脿 un prix indiqu茅 de 13,86 $ par action. La d茅claration pr茅cise explicitement qu鈥檌l ne s鈥檃git pas d鈥檜ne vente sur le march茅 ouvert ; les actions ont 茅t茅 restitu茅es 脿 l鈥櫭﹎etteur. Apr猫s la retenue, Richmond d茅tient toujours 214 694 actions 脿 titre b茅n茅ficiaire, un chiffre incluant les RSU non acquises. Aucun instrument d茅riv茅 n鈥檃 茅t茅 d茅clar茅, et il n鈥檡 a eu ni achats ni ventes discr茅tionnaires. 脡tant donn茅 le faible nombre d鈥檃ctions concern茅es (鈮�0,4 % des avoirs de l鈥檌niti茅) et la nature routini猫re de la retenue fiscale, la transaction est consid茅r茅e comme administrative et sans impact sur la th猫se d鈥檌nvestissement de la soci茅t茅.
Aehr Test Systems (AEHR) 鈥� Insider-Meldung Form 4: Chief Technology Officer Donald P. Richmond II hat am 14. Juli 2025 insgesamt 811 Stammaktien einbehalten (Transaktionscode F), um Steuerverpflichtungen aus der Vesting von Restricted Stock Units (RSUs) zu erf眉llen, zu einem angegebenen Preis von 13,86 $ pro Aktie. In der Meldung wird ausdr眉cklich darauf hingewiesen, dass dies kein Verkauf am offenen Markt ist; die Aktien wurden an den Emittenten zur眉ckgegeben. Nach der Einbehaltung besitzt Richmond weiterhin 214.694 Aktien wirtschaftlich, einschlie脽lich unverfallbarer RSUs. Es wurden keine Derivate gemeldet, ebenso keine K盲ufe oder diskretion盲ren Verk盲ufe. Aufgrund der geringen Anzahl der betroffenen Aktien (ca. 0,4 % der Insider-Beteiligung) und der routinem盲脽igen Natur der steuerbedingten Einbehaltung wird die Transaktion als administrativ und unerheblich f眉r die Investmentthese des Unternehmens eingestuft.
FAQ
What did AEHR's CTO report in the latest Form 4?
How many AEHR shares does Donald P. Richmond II now own?
What is Transaction Code F in AEHR's Form 4?
Was there any cash sale of AEHR stock by the insider?
Does this Form 4 have material impact on AEHR investors?
